e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Role of infection in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An experimental model of rhinovirus-induced COPD exacerbation
P. Mallia, T. Kebadze, S. Message, S. Johnston (London, United Kingdom)
Source:
Annual Congress 2004 - Role of infection in COPD
Session:
Role of infection in COPD
Session type:
Oral Presentation
Number:
4203
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Mallia, T. Kebadze, S. Message, S. Johnston (London, United Kingdom). An experimental model of rhinovirus-induced COPD exacerbation. Eur Respir J 2004; 24: Suppl. 48, 4203
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Related content which might interest you:
Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006
Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
The character of COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 34s
Year: 2006
IL-18 in infectious exacerbations of COPD
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017
Prediction models for exacerbations in patients with COPD
Source: Eur Respir Rev 2017; 26: 160061
Year: 2017
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
The importance of eosinophilic inflammation in COPD exacerbations
Source: International Congress 2017 – COPD management
Year: 2017
Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Modelling exacerbations of COPD
Source: Annual Congress 2012 - Modelling respiratory infections: is it the future or the present?
Year: 2012
Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005
Bacterial burden in rhinovirus-induced asthma exacerbations
Source: Lung Science Conference 2015
Year: 2015
Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept